Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 2005, p. 3554-3557, Vol. 49, No. 8
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.8.3554-3557.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Novel Mechanism of Resistance to Oxazolidinones, Macrolides, and Chloramphenicol in Ribosomal Protein L4 of the Pneumococcus
Nicole Wolter,1*
Anthony M. Smith,1
David J. Farrell,2
William Schaffner,3
Matthew Moore,4
Cynthia G. Whitney,4
James H. Jorgensen,5 and
Keith P. Klugman1,6
MRC/NICD/WITS Respiratory and Meningeal Pathogens Research Unit, National Institute for Communicable Diseases and University of the Witwatersrand, Johannesburg, South Africa,1
GR Micro Ltd., London, United Kingdom,2
Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee,3
Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia,4
Department of Pathology, University of Texas Health Science Center, San Antonio, Texas,5
Department of Global Health, Rollins School of Public Health, and Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, Georgia6
Received 16 February 2005/
Returned for modification 18 March 2005/
Accepted 21 May 2005
Two clinical Streptococcus pneumoniae isolates, identified as resistant to macrolides and chloramphenicol and nonsusceptible to linezolid, were found to contain 6-bp deletions in the gene encoding riboprotein L4. The gene transformed susceptible strain R6 so that it exhibited such resistance, with the transformants also showing a fitness cost. We demonstrate a novel bacterial mechanism of resistance to chloramphenicol and nonsusceptibility to linezolid.
* Corresponding author. Mailing address
: Respiratory and Meningeal Pathogens Research Unit, National Institute for Communicable Diseases, P.O. Box 1038, Johannesburg, 2000, South Africa. Phone: 27 11 489 9335. Fax: 27 11 489 9332. E-mail:
nicole.edmondson{at}nhls.ac.za.
Antimicrobial Agents and Chemotherapy, August 2005, p. 3554-3557, Vol. 49, No. 8
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.8.3554-3557.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
LaPlante, K. L., Sakoulas, G.
(2009). Evaluating Aztreonam and Ceftazidime Pharmacodynamics with Escherichia coli in Combination with Daptomycin, Linezolid, or Vancomycin in an In Vitro Pharmacodynamic Model. Antimicrob. Agents Chemother.
53: 4549-4555
[Abstract]
[Full Text]
-
Feng, J., Lupien, A., Gingras, H., Wasserscheid, J., Dewar, K., Legare, D., Ouellette, M.
(2009). Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance. Genome Res
19: 1214-1223
[Abstract]
[Full Text]
-
Lawrence, M. G., Lindahl, L., Zengel, J. M.
(2008). Effects on Translation Pausing of Alterations in Protein and RNA Components of the Ribosome Exit Tunnel. J. Bacteriol.
190: 5862-5869
[Abstract]
[Full Text]
-
Lawrence, L., Danese, P., DeVito, J., Franceschi, F., Sutcliffe, J.
(2008). In Vitro Activities of the Rx-01 Oxazolidinones against Hospital and Community Pathogens. Antimicrob. Agents Chemother.
52: 1653-1662
[Abstract]
[Full Text]
-
Arias, C. A., Vallejo, M., Reyes, J., Panesso, D., Moreno, J., Castaneda, E., Villegas, M. V., Murray, B. E., Quinn, J. P.
(2008). Clinical and Microbiological Aspects of Linezolid Resistance Mediated by the cfr Gene Encoding a 23S rRNA Methyltransferase. J. Clin. Microbiol.
46: 892-896
[Abstract]
[Full Text]
-
Binet, R., Maurelli, A. T.
(2007). Frequency of Development and Associated Physiological Cost of Azithromycin Resistance in Chlamydia psittaci 6BC and C. trachomatis L2. Antimicrob. Agents Chemother.
51: 4267-4275
[Abstract]
[Full Text]
-
Richter, E., Rusch-Gerdes, S., Hillemann, D.
(2007). First Linezolid-Resistant Clinical Isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother.
51: 1534-1536
[Abstract]
[Full Text]
-
Sidhu, A. B. S., Sun, Q., Nkrumah, L. J., Dunne, M. W., Sacchettini, J. C., Fidock, D. A.
(2007). In Vitro Efficacy, Resistance Selection, and Structural Modeling Studies Implicate the Malarial Parasite Apicoplast as the Target of Azithromycin. J. Biol. Chem.
282: 2494-2504
[Abstract]
[Full Text]
-
Jones, R. N., Ross, J. E., Fritsche, T. R., Sader, H. S.
(2006). Comment on: Linezolid resistance in coagulase-negative staphylococci2. J Antimicrob Chemother
58: 899-900
[Full Text]
-
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., Vester, B.
(2006). The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A Antibiotics.. Antimicrob. Agents Chemother.
50: 2500-2505
[Abstract]
[Full Text]
-
Jones, R. N., Ross, J. E., Fritsche, T. R., Sader, H. S.
(2006). Oxazolidinone susceptibility patterns in 2004: report from the Zyvox(R) Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations. J Antimicrob Chemother
57: 279-287
[Abstract]
[Full Text]
-
Wolter, N., Smith, A. M., Farrell, D. J., Klugman, K. P.
(2006). Heterogeneous Macrolide Resistance and Gene Conversion in the Pneumococcus. Antimicrob. Agents Chemother.
50: 359-361
[Abstract]
[Full Text]